Biotherapy monitoring, a major area of interest at the European Crohn's and Colitis Organisation (ECCO) Congress
Lycera Announces Presentations of Positive Preclinical Results for Lead Candidate LYC-30937 and for Selective Rho kinase Inhibitor Program at the 11th Congress of the European Crohn's and Colitis Organization (ECCO)
![Amsterdam RAI EACCME applied Register online at Inflammatory Bowel Diseases 2016 IBD innovations driving clinical decisions. - ppt download Amsterdam RAI EACCME applied Register online at Inflammatory Bowel Diseases 2016 IBD innovations driving clinical decisions. - ppt download](https://images.slideplayer.com/26/8625279/slides/slide_1.jpg)
Amsterdam RAI EACCME applied Register online at Inflammatory Bowel Diseases 2016 IBD innovations driving clinical decisions. - ppt download
![Gianluca Pellino on Twitter: Gianluca Pellino on Twitter:](https://pbs.twimg.com/media/CdvS2hMWwAAyhCL.jpg:large)